Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol: A Randomized Controlled Trial episode artwork

EPISODE · Nov 15, 2011 · 2 MIN

Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol: A Randomized Controlled Trial

from Healthy Dialogue

Interview with Steven E. Nissen, MD, author of Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol: A Randomized Controlled Trial

Episode metadata supplied by the publisher feed · Published Nov 15, 2011

Embed this episode

NOW PLAYING

Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol: A Randomized Controlled Trial

0:00 2:59

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Healthy Dialogue?

This episode is 2 minutes long.

When was this Healthy Dialogue episode published?

This episode was published on November 15, 2011.

Can I download this Healthy Dialogue episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!